Literature DB >> 26764154

Clinical trials for neurodevelopmental disorders: At a therapeutic frontier.

Shafali S Jeste1, Daniel H Geschwind2.   

Abstract

A well-powered clinical trial that failed to replicate promising results in animal models of fragile X syndrome yields important lessons for clinical trial design (Berry-Kravis et al., this issue).
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26764154     DOI: 10.1126/scitranslmed.aad9874

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  24 in total

1.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

2.  Developmental timing and critical windows for the treatment of psychiatric disorders.

Authors:  Oscar Marín
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

Review 3.  Advancing the understanding of autism disease mechanisms through genetics.

Authors:  Luis de la Torre-Ubieta; Hyejung Won; Jason L Stein; Daniel H Geschwind
Journal:  Nat Med       Date:  2016-04       Impact factor: 53.440

4.  A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials.

Authors:  Melissa Raspa; Carla M Bann; Angela Gwaltney; Timothy A Benke; Cary Fu; Daniel G Glaze; Richard Haas; Peter Heydemann; Mary Jones; Walter E Kaufmann; David Lieberman; Eric Marsh; Sarika Peters; Robin Ryther; Shannon Standridge; Steven A Skinner; Alan K Percy; Jeffrey L Neul
Journal:  Am J Intellect Dev Disabil       Date:  2020-11-01

Review 5.  Disrupted circuits in mouse models of autism spectrum disorder and intellectual disability.

Authors:  Carla Em Golden; Joseph D Buxbaum; Silvia De Rubeis
Journal:  Curr Opin Neurobiol       Date:  2017-12-07       Impact factor: 6.627

Review 6.  Lessons learned from studying syndromic autism spectrum disorders.

Authors:  Yehezkel Sztainberg; Huda Y Zoghbi
Journal:  Nat Neurosci       Date:  2016-10-26       Impact factor: 24.884

7.  Schizophrenia genetics complements its mechanistic understanding.

Authors:  Elizabeth K Ruzzo; Daniel H Geschwind
Journal:  Nat Neurosci       Date:  2016-03-21       Impact factor: 24.884

Review 8.  Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.

Authors:  Dejan B Budimirovic; Elizabeth Berry-Kravis; Craig A Erickson; Scott S Hall; David Hessl; Allan L Reiss; Margaret K King; Leonard Abbeduto; Walter E Kaufmann
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

Review 9.  The road to precision psychiatry: translating genetics into disease mechanisms.

Authors:  Michael J Gandal; Virpi Leppa; Hyejung Won; Neelroop N Parikshak; Daniel H Geschwind
Journal:  Nat Neurosci       Date:  2016-10-26       Impact factor: 24.884

10.  Evaluating atypical language in autism using automated language measures.

Authors:  Alexandra C Salem; Heather MacFarlane; Joel R Adams; Grace O Lawley; Jill K Dolata; Steven Bedrick; Eric Fombonne
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.